Development of rationally designed affinity-based drug delivery systems.
about
A review of bioactive release from nerve conduits as a neurotherapeutic strategy for neuronal growth in peripheral nerve injuryAffinity-Based Drug DeliveryTunable growth factor delivery from injectable hydrogels for tissue engineering.Design of growth factor sequestering biomaterialsAffinity-based release of polymer-binding peptides from hydrogels with the target segments of peptides.Approaches to neural tissue engineering using scaffolds for drug deliveryUsing glycosaminoglycan/chemokine interactions for the long-term delivery of 5P12-RANTES in HIV prevention.Incorporation of heparin into biomaterials.From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF)Designer protein delivery: From natural to engineered affinity-controlled release systems.Improvements in biomaterial matrices for neural precursor cell transplantationControlled release and gradient formation of human glial-cell derived neurotrophic factor from heparinated poly(ethylene glycol) microsphere-based scaffolds.Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels.Gene therapy vectors with enhanced transfection based on hydrogels modified with affinity peptides.The formation of protein concentration gradients mediated by density differences of poly(ethylene glycol) microspheres.The effects of soluble growth factors on embryonic stem cell differentiation inside of fibrin scaffoldsDevelopment of affinity-based delivery of NGF from a chondroitin sulfate biomaterial.Release rate controls biological activity of nerve growth factor released from fibrin matrices containing affinity-based delivery systems.Injectable Hyaluronan Hydrogels with Peptide-Binding Dendrimers Modulate the Controlled Release of BMP-2 and TGF-β1
P2860
Q27027789-5719C696-B2EE-45A0-9E7A-D5D420319A12Q29543246-143FD757-6E9B-4933-BA24-44C2953B9CB0Q30010186-2576F499-C25B-4B3F-8885-8A7A16DE5EC0Q34543371-67B09BF6-CAAB-4ED2-BDB5-4235246A9462Q35855153-B22FA423-FF4F-484F-BD4D-59D656195221Q35990610-990830B9-5560-41A4-833A-323C8D619F75Q37458024-24998C04-C12B-4558-A357-A9A48B777F3EQ38135949-330388C0-3C1F-4D0A-8FFE-2C006572285DQ38168376-64330016-6A44-4BDD-AE69-A5496FBD2A5CQ38293159-B877FEE9-1C09-440F-9793-D689BE03DB13Q38521737-CBE48E6D-D9B3-43DF-908A-9C4C76CFEC36Q38996239-5C4D5BDB-3EF9-4A39-8580-C2F85022B2FDQ39508968-4F0AF076-C1DF-47BA-A3A9-25E32D41F6FBQ39554236-265C5C12-9573-4C46-8873-26D3C2957C50Q39666100-8B821B29-DAA7-49F5-ABEB-D3CD441C03AEQ41875141-605E149C-296E-4331-B222-82DCE026EFCCQ42861076-0F264366-A3C1-4ED8-B7E5-2636F4518B3FQ50962974-DB699577-7BE5-4676-A1D0-A05F6C9A58B0Q57342795-0C8978D9-CB57-4A2C-8E29-8524A90EA427
P2860
Development of rationally designed affinity-based drug delivery systems.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Development of rationally designed affinity-based drug delivery systems.
@ast
Development of rationally designed affinity-based drug delivery systems.
@en
type
label
Development of rationally designed affinity-based drug delivery systems.
@ast
Development of rationally designed affinity-based drug delivery systems.
@en
prefLabel
Development of rationally designed affinity-based drug delivery systems.
@ast
Development of rationally designed affinity-based drug delivery systems.
@en
P2093
P1433
P1476
Development of rationally designed affinity-based drug delivery systems.
@en
P2093
Brandon C Hicks
Dustin J Maxwell
Sarah Parsons
Shelly E Sakiyama-Elbert
P304
P356
10.1016/J.ACTBIO.2004.09.002
P577
2005-01-01T00:00:00Z